Robin Elliott

17.6k total citations · 1 hit paper
5 papers, 1.0k citations indexed

About

Robin Elliott is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Robin Elliott has authored 5 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Immunology. Recurrent topics in Robin Elliott's work include Bone health and treatments (2 papers), Bone Metabolism and Diseases (2 papers) and HER2/EGFR in Cancer Research (1 paper). Robin Elliott is often cited by papers focused on Bone health and treatments (2 papers), Bone Metabolism and Diseases (2 papers) and HER2/EGFR in Cancer Research (1 paper). Robin Elliott collaborates with scholars based in United States, South Korea and Canada. Robin Elliott's co-authors include William J. Boyle, Josef Penninger, Jimmie E. Fata, Junko Irie-Sasaki, Evelyn B. Voura, Young‐Yun Kong, Roger A. Moorehead, Takehiko Sasaki, Sheila Scully and David L. Lacey and has published in prestigious journals such as Nature, Cell and Journal of Biological Chemistry.

In The Last Decade

Robin Elliott

5 papers receiving 984 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Osteoclast Differentiation Factor Osteoprotegerin-Ligand Is Essential for Mammary Gland Development

2000 596 citations Jimmie E. Fata, Young‐Yun Kong et al. Cell profile →

Peers

Countries citing papers authored by Robin Elliott

Since Specialization

Citations

This map shows the geographic impact of Robin Elliott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin Elliott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin Elliott more than expected).

Fields of papers citing papers by Robin Elliott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin Elliott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin Elliott. The network helps show where Robin Elliott may publish in the future.

Co-authorship network of co-authors of Robin Elliott

This figure shows the co-authorship network connecting the top 25 collaborators of Robin Elliott. A scholar is included among the top collaborators of Robin Elliott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robin Elliott. Robin Elliott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

#	Work	Indexed citations
1	Generation and Characterization of Fully Human Monoclonal Antibodies Against Human Orai1 for Autoimmune Disease 2013 ·Journal of Pharmacology and Experimental Therapeutics ·Fen‐Fen Lin, Robin Elliott, Anne Colombero, Kevin Gaida, Laura A. Kelley, (unknown), Shu-Yin Ho, (unknown), Min Wong, Palaniswami Rathanaswami, (unknown), John K. Sullivan, Hung Q. Nguyen, Helen J. McBride	63
2	197 POSTER Denosumab is a selective inhibitor of human receptor activator of NF-kB ligand that blocks osteoclast formation in vitro and in vivo 2006 ·European Journal of Cancer Supplements ·Robin Elliott, Paul J. Kostenuik, (unknown), (unknown), Nessa Hawkins, (unknown), Susan McCabe, (unknown), John Sullivan, William C. Dougall	12
3	The Osteoclast Differentiation Factor Osteoprotegerin-Ligand Is Essential for Mammary Gland Development breakdown → 2000 ·Cell ·Jimmie E. Fata, Young‐Yun Kong, (unknown), Takehiko Sasaki, Junko Irie-Sasaki, Roger A. Moorehead, Robin Elliott, Sheila Scully, Evelyn B. Voura, David L. Lacey, William J. Boyle, Rama Khokha, Josef Penninger	596
4	ATAR, a Novel Tumor Necrosis Factor Receptor Family Member, Signals through TRAF2 and TRAF5 1997 ·Journal of Biological Chemistry ·Hailing Hsu, (unknown), Anne Colombero, Robin Elliott, Michael J. Kelley, William J. Boyle	148
5	B61 is a ligand for the ECK receptor protein-tyrosine kinase 1994 ·Nature ·(unknown), R.W.G. Hunt, (unknown), William J. Boyle, Vann P. Parker, Richard Lindberg, Hsieng S. Lu, Anne Colombero, Robin Elliott, Brenda Guthrie, (unknown), (unknown), Robert Toso, Ming Zhang, (unknown), (unknown), Brian Varnum, Yosef Yarden, Tony Hunter, Gary M. Fox	194

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact